Literature DB >> 15710873

Phosphatase and tensin homologue growth suppression without phosphatase.

David Stokoe1, Joseph F Costello.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15710873      PMCID： PMC549471          DOI： 10.1073/pnas.0500089102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  12 in total

1.  Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.

Authors:  Myrto Raftopoulou; Sandrine Etienne-Manneville; Annette Self; Sarah Nicholls; Alan Hall
Journal:  Science       Date:  2004-02-20       Impact factor: 47.728

2.  P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.

Authors:  M P Myers; J P Stolarov; C Eng; J Li; S I Wang; M H Wigler; R Parsons; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity.

Authors:  A Hlobilkova; P Guldberg; M Thullberg; J Zeuthen; J Lukas; J Bartek
Journal:  Exp Cell Res       Date:  2000-05-01       Impact factor: 3.905

4.  The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.

Authors:  T Maehama; J E Dixon
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

5.  PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.

Authors:  Daniel J Freeman; Andrew G Li; Gang Wei; Heng-Hong Li; Nathalie Kertesz; Ralf Lesche; Andrew D Whale; Hilda Martinez-Diaz; Nora Rozengurt; Robert D Cardiff; Xuan Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

6.  Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor.

Authors:  Koichi Okumura; Mujun Zhao; Ronald A Depinho; Frank B Furnari; Webster K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-19       Impact factor: 11.205

7.  Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.

Authors:  J O Lee; H Yang; M M Georgescu; A Di Cristofano; T Maehama; Y Shi; J E Dixon; P Pandolfi; N P Pavletich
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

8.  Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma.

Authors:  David C Whiteman; Xiao-Ping Zhou; Margaret C Cummings; Sandra Pavey; Nicholas K Hayward; Charis Eng
Journal:  Int J Cancer       Date:  2002-05-01       Impact factor: 7.396

9.  TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).

Authors:  A G Bader; M L Schneider; K Bister; M Hartl
Journal:  Oncogene       Date:  2001-11-08       Impact factor: 9.867

Review 10.  PTEN: one gene, many syndromes.

Authors:  Charis Eng
Journal:  Hum Mutat       Date:  2003-09       Impact factor: 4.878
View more
  2 in total

1.  Tumor suppression by PTEN requires the activation of the PKR-eIF2alpha phosphorylation pathway.

Authors:  Zineb Mounir; Jothi Latha Krishnamoorthy; Gavin P Robertson; Donalyn Scheuner; Randal J Kaufman; Maria-Magdalena Georgescu; Antonis E Koromilas
Journal:  Sci Signal       Date:  2009-12-22       Impact factor: 8.192

2.  Incorporation of phosphatase inhibitor in culture prompts growth initiation of isolated non-growing oocytes.

Authors:  Kanako Morohaku; Yumi Hoshino; Hiroshi Sasada; Eimei Sato
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.